Access cutting-edge phenylketonuria treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access phenylketonuria specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related phenylketonuria treatment provided free
The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.
Sponsor: PTC Therapeutics
Check if you qualify for this phenylketonuria clinical trial in Indianapolis, IN
If you're searching for phenylketonuria treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced phenylketonuria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.